Moteur de recherche d’entreprises européennes
Financement de l’UE (3 946 286 €) : Intégration de la spectroscopie par résonance magnétique et de l’imagerie multimodale pour la recherche et l’enseignement en MEDicine Hor16/11/2018 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Intégration de la spectroscopie par résonance magnétique et de l’imagerie multimodale pour la recherche et l’enseignement en MEDicine
INSPiRE-MED will provide research and training to 15 early career researchers in the field of medical imaging, specifically Magnetic Resonance Spectroscopy (MRS) and Spectroscopic Imaging (MRSI), combined with MR Imaging and Positron Emission Tomography (PET). INSPiRE-MED Fellows will acquire skills to develop careers contributing to innovative technological advances in medical imaging in a multi-disciplinary environment encompassing physics, mathematical and computer sciences leading to applications in medicine and biological sciences. The 12 academic and 9 industrial partners will provide the Fellows with transferable and generic skills as well as a comprehensive, wide-ranging education on the basic principles of medical imaging and image analysis. This fundamental knowledge will be combined with in-depth learning in a specific area, through local delivery via graduate schools, programme-wide INSPiRE-MED training activities and workshops and personal academic supervision by two INSPiRE-MED supervisors. This will enable them to successfully participate in developing new tools for clinicians. MRS is a unique, non-invasive molecular technique that has proved useful for diagnosis and therapy management in disease models and patients. Despite its potential, the clinical uptake of MRS has lagged behind that of MRI and PET. Thus, INSPiRE-MED will have 3 objectives, encapsulated in 3 research Work Packages (WP): 1) Development of novel acquisition and processing techniques allowing MRS(I) to become a key tool in medical imaging (WP1); 2) Integration of innovative MRS(I) techniques in several key clinical and pre-clinical applications including a multimodal metabolic approach based on MR/PET (WP2); 3) Translation of most advanced research in MRS(I) and machine learning into clinical routine by means of a fully automatic software suite, building on the well-known jMRUI package (http://www.jmrui.eu) to provide a prime tool in personalized medicine (WP 3).
| BRUKER BIOSPIN MRI GmbH | ? |
| Consorcio Centro de Investigacion Biomedica en Red M.P | 250 905 € |
| ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE | 281 277 € |
| Icometrix N.V. | 256 320 € |
| Katholieke Universiteit Leuven | 512 640 € |
| MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN e. V. | 252 788 € |
| MR COILS B.V. | 14 240,18 € |
| STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM | 177 080 € |
| STICHTING RADBOUD UNIVERSITEIT | 88 540 € |
| The University of Manchester | 303 173 € |
| UNIVERSITAET BERN | 585 524 € |
| UNIVERSITAIR MEDISCH CENTRUM UTRECHT | 251 380 € |
| Universitat Autonoma de Barcelona | 250 905 € |
| Universite Lyon 1 Claude Bernard | 274 802 € |
| Ustav Pristrojove Techniky Avcr Vvi | 446 713 € |
https://cordis.europa.eu/project/id/813120
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Bruker BioSpin MRI GmbH, Ettlingen, Allemagne.
Les visualisations de "BRUKER BIOSPIN MRI GmbH - Financement de l’UE (3 946 286 €) : Intégration de la spectroscopie par résonance magnétique et de l’imagerie multimodale pour la recherche et l’enseignement en MEDicine"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
